BioVaxys Technology Corp.
BIOV
CNSX
07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
---|---|---|---|---|---|
Net Income | -3.58M | -4.83M | -5.53M | -6.63M | -10.35M |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 2.02M | 2.66M | 3.38M | 4.08M | 8.27M |
Change in Net Operating Assets | 940.80K | 1.83M | 1.61M | 1.77M | 1.14M |
Cash from Operations | -622.70K | -339.50K | -543.00K | -780.20K | -935.80K |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -778.50K | -778.50K | -- | -- | -- |
Cash from Investing | -778.50K | -778.50K | -- | -- | -- |
Total Debt Issued | 13.80K | -- | -- | -- | -- |
Total Debt Repaid | -33.40K | -33.40K | -- | -- | -- |
Issuance of Common Stock | 2.41M | 1.68M | 1.63M | 917.10K | 1.27M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -25.30K |
Cash from Financing | 1.76M | 1.22M | 1.21M | 678.00K | 924.90K |
Foreign Exchange rate Adjustments | 1.10K | -2.00K | -3.00K | -2.40K | -16.90K |
Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
Net Change in Cash | 362.80K | 100.00K | 661.70K | -104.50K | -27.60K |